Tekmira Inks RNAi Product-Development, Manufacturing Deal with Roche

Tekmira will receive up to $18.4 million to help it develop two undisclosed candidates through the IND stage, and could get up to $32 million in milestones, plus royalties on product sales.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories